# Nuclide record f-regulation-reimbursement (section). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/fronts/f-regulation-reimbursement/>
  a schema:DefinedTerm ;
  nuclide:kind "section" ;
  schema:identifier "f-regulation-reimbursement" ;
  schema:name "Regulation & reimbursement"@en ;
  schema:description "Getting one of these radioactive medicines approved and then actually paid for is its own specialised process, separate from ordinary drugs, and the rules for who pays what changed again for 2026 in the US."@en ;
  schema:url <https://nuclide.cc/fronts/f-regulation-reimbursement/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.cms.gov/files/document/mm14361-hospital-outpatient-prospective-payment-system-january-2026-update.pdf>, <https://www.sidley.com/en/insights/newsupdates/2025/12/medicare-payment-policy-final-rule-for-outpatient-setting-addresses-radiopharmaceuticals>, <https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-quality-radiopharmaceuticals-revision-2_en.pdf>, <https://www.gov.uk/guidance/clinical-trials-for-medicines-good-manufacturing-practice-and-radiopharmaceutical-investigational-medicinal-products> ;
  nuclide:related <https://nuclide.cc/fronts/f-radiochemistry/>, <https://nuclide.cc/fronts/f-dosimetry/>, <https://nuclide.cc/fronts/f-isotope-supply/>, <https://nuclide.cc/isotopes/tc-99m/>, <https://nuclide.cc/isotopes/mo-99/> ;
  nuclide:institutions <https://nuclide.cc/institutions/ema/>, <https://nuclide.cc/institutions/mhra/>, <https://nuclide.cc/institutions/pmda/>, <https://nuclide.cc/institutions/snmmi/>, <https://nuclide.cc/institutions/eanm/> ;
  nuclide:terms <https://nuclide.cc/terms/medicare-ced/> .